Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/243"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1144"
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:Evidence_enzyme_system	""
dc:creator	"boycer"
dc:date	"09/23/2009 16:07:07"
?:content	"Metabolism Following oral administration, eszopiclone is extensively metabolized by oxidation and demethylation. The primary plasma metabolites are (S)-zopiclone-N-oxide and (S)-N-desmethyl zopiclone; the latter compound binds to GABA receptors with substantially lower potency than eszopiclone, and the former compound shows no significant binding to this receptor."
rdfs:seeAlso	?:fd047b2b-05a6-4d99-95cb-955f14bf329f

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ eszopiclone_has_metabolite_S-N-desmethylzopiclone, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1144 }

Context graph